Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46...
Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
About this item
Full title
Author / Creator
Guilhem, Alexandre , Fargeton, Anne-Emmanuelle , Simon, Anne-Claire , Duffau, Pierre , Harle, Jean-Robert , Lavigne, Christian , Carette, Marie-France , Bletry, Olivier , Kaminsky, Pierre , Leguy, Vanessa , Lerolle, Nathalie , Roux, Dominique , Lambert, Marc , Chinet, Thierry , Bonnet, Delphine , Dupuis-Girod, Sophie and Rivière, Sophie
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Bevacizumab, an anti-VEGF monoclonal antibody, has recently emerged as a new option for severe forms of hereditary hemorrhagic telangiectasia (HHT). Its utilization in this orphan disease has rapidly spread despite the lack of randomized trials and international guidelines. The objective of this study is to report the main clinical data (baseline c...
Alternative Titles
Full title
Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
Authors, Artists and Contributors
Author / Creator
Fargeton, Anne-Emmanuelle
Simon, Anne-Claire
Duffau, Pierre
Harle, Jean-Robert
Lavigne, Christian
Carette, Marie-France
Bletry, Olivier
Kaminsky, Pierre
Leguy, Vanessa
Lerolle, Nathalie
Roux, Dominique
Lambert, Marc
Chinet, Thierry
Bonnet, Delphine
Dupuis-Girod, Sophie
Rivière, Sophie
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_acf4a8c5dee84f868f1a92cce5b9d24f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_acf4a8c5dee84f868f1a92cce5b9d24f
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0188943
